Conditions associated with circulating tumor-associated folate receptor 1 protein in healthy men and women.
Identifieur interne : 000751 ( PubMed/Curation ); précédent : 000750; suivant : 000752Conditions associated with circulating tumor-associated folate receptor 1 protein in healthy men and women.
Auteurs : Linda E. Kelemen [Canada] ; James D. Brenton [Royaume-Uni] ; Christine Parkinson [Royaume-Uni] ; Hayley C Whitaker [Royaume-Uni] ; Anna M. Piskorz [Royaume-Uni] ; Ilona Csizmadi [Canada] ; Paula J. Robson [Canada]Source :
- PloS one [ 1932-6203 ] ; 2014.
English descriptors
- KwdEn :
- MESH :
- chemical , blood : Folate Receptor 1.
- Adult, Aged, Cohort Studies, Diet, Female, Healthy Volunteers, Humans, Life Style, Male, Middle Aged, Pregnancy, Reference Values, Reproduction.
Abstract
Serum concentrations of the tumor-associated folate receptor 1 (FOLR1) protein may be a marker for early cancer detection, yet concentrations have also been detected in cancer-free women. We investigated the conditions associated with circulating FOLR1 protein in healthy individuals and sought to clarify the range of normal serum values.
DOI: 10.1371/journal.pone.0096542
PubMed: 24810481
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000751
Links to Exploration step
pubmed:24810481Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Conditions associated with circulating tumor-associated folate receptor 1 protein in healthy men and women.</title><author><name sortKey="Kelemen, Linda E" sort="Kelemen, Linda E" uniqKey="Kelemen L" first="Linda E" last="Kelemen">Linda E. Kelemen</name><affiliation wicri:level="1"><nlm:affiliation>Department of Population Health Research, Alberta Health Services, Calgary, Alberta, Canada; Department of Medical Genetics, University of Calgary, Calgary, Alberta, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Population Health Research, Alberta Health Services, Calgary, Alberta, Canada; Department of Medical Genetics, University of Calgary, Calgary, Alberta</wicri:regionArea></affiliation></author><author><name sortKey="Brenton, James D" sort="Brenton, James D" uniqKey="Brenton J" first="James D" last="Brenton">James D. Brenton</name><affiliation wicri:level="1"><nlm:affiliation>Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom; Department of Oncology, University of Cambridge, Hutchison/Medical Research Council Research Centre, Cambridge, United Kingdom; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, United Kingdom; Cambridge Experimental Cancer Medicine Centre, Cambridge, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom; Department of Oncology, University of Cambridge, Hutchison/Medical Research Council Research Centre, Cambridge, United Kingdom; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, United Kingdom; Cambridge Experimental Cancer Medicine Centre, Cambridge</wicri:regionArea></affiliation></author><author><name sortKey="Parkinson, Christine" sort="Parkinson, Christine" uniqKey="Parkinson C" first="Christine" last="Parkinson">Christine Parkinson</name><affiliation wicri:level="1"><nlm:affiliation>Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge</wicri:regionArea></affiliation></author><author><name sortKey="C Whitaker, Hayley" sort="C Whitaker, Hayley" uniqKey="C Whitaker H" first="Hayley" last="C Whitaker">Hayley C Whitaker</name><affiliation wicri:level="1"><nlm:affiliation>Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom; Department of Oncology, University of Cambridge, Hutchison/Medical Research Council Research Centre, Cambridge, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom; Department of Oncology, University of Cambridge, Hutchison/Medical Research Council Research Centre, Cambridge</wicri:regionArea></affiliation></author><author><name sortKey="Piskorz, Anna M" sort="Piskorz, Anna M" uniqKey="Piskorz A" first="Anna M" last="Piskorz">Anna M. Piskorz</name><affiliation wicri:level="1"><nlm:affiliation>Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge</wicri:regionArea></affiliation></author><author><name sortKey="Csizmadi, Ilona" sort="Csizmadi, Ilona" uniqKey="Csizmadi I" first="Ilona" last="Csizmadi">Ilona Csizmadi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Population Health Research, Alberta Health Services, Calgary, Alberta, Canada; Departments of Oncology and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Population Health Research, Alberta Health Services, Calgary, Alberta, Canada; Departments of Oncology and Community Health Sciences, University of Calgary, Calgary, Alberta</wicri:regionArea></affiliation></author><author><name sortKey="Robson, Paula J" sort="Robson, Paula J" uniqKey="Robson P" first="Paula J" last="Robson">Paula J. Robson</name><affiliation wicri:level="1"><nlm:affiliation>Alberta Health Services, Edmonton, Alberta, Canada; Department of Agricultural, Food and Nutritional Sciences, University of Alberta, Edmonton, Alberta, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Alberta Health Services, Edmonton, Alberta, Canada; Department of Agricultural, Food and Nutritional Sciences, University of Alberta, Edmonton, Alberta</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24810481</idno><idno type="pmid">24810481</idno><idno type="doi">10.1371/journal.pone.0096542</idno><idno type="wicri:Area/PubMed/Corpus">000751</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000751</idno><idno type="wicri:Area/PubMed/Curation">000751</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000751</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Conditions associated with circulating tumor-associated folate receptor 1 protein in healthy men and women.</title><author><name sortKey="Kelemen, Linda E" sort="Kelemen, Linda E" uniqKey="Kelemen L" first="Linda E" last="Kelemen">Linda E. Kelemen</name><affiliation wicri:level="1"><nlm:affiliation>Department of Population Health Research, Alberta Health Services, Calgary, Alberta, Canada; Department of Medical Genetics, University of Calgary, Calgary, Alberta, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Population Health Research, Alberta Health Services, Calgary, Alberta, Canada; Department of Medical Genetics, University of Calgary, Calgary, Alberta</wicri:regionArea></affiliation></author><author><name sortKey="Brenton, James D" sort="Brenton, James D" uniqKey="Brenton J" first="James D" last="Brenton">James D. Brenton</name><affiliation wicri:level="1"><nlm:affiliation>Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom; Department of Oncology, University of Cambridge, Hutchison/Medical Research Council Research Centre, Cambridge, United Kingdom; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, United Kingdom; Cambridge Experimental Cancer Medicine Centre, Cambridge, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom; Department of Oncology, University of Cambridge, Hutchison/Medical Research Council Research Centre, Cambridge, United Kingdom; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, United Kingdom; Cambridge Experimental Cancer Medicine Centre, Cambridge</wicri:regionArea></affiliation></author><author><name sortKey="Parkinson, Christine" sort="Parkinson, Christine" uniqKey="Parkinson C" first="Christine" last="Parkinson">Christine Parkinson</name><affiliation wicri:level="1"><nlm:affiliation>Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge</wicri:regionArea></affiliation></author><author><name sortKey="C Whitaker, Hayley" sort="C Whitaker, Hayley" uniqKey="C Whitaker H" first="Hayley" last="C Whitaker">Hayley C Whitaker</name><affiliation wicri:level="1"><nlm:affiliation>Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom; Department of Oncology, University of Cambridge, Hutchison/Medical Research Council Research Centre, Cambridge, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom; Department of Oncology, University of Cambridge, Hutchison/Medical Research Council Research Centre, Cambridge</wicri:regionArea></affiliation></author><author><name sortKey="Piskorz, Anna M" sort="Piskorz, Anna M" uniqKey="Piskorz A" first="Anna M" last="Piskorz">Anna M. Piskorz</name><affiliation wicri:level="1"><nlm:affiliation>Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge</wicri:regionArea></affiliation></author><author><name sortKey="Csizmadi, Ilona" sort="Csizmadi, Ilona" uniqKey="Csizmadi I" first="Ilona" last="Csizmadi">Ilona Csizmadi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Population Health Research, Alberta Health Services, Calgary, Alberta, Canada; Departments of Oncology and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Population Health Research, Alberta Health Services, Calgary, Alberta, Canada; Departments of Oncology and Community Health Sciences, University of Calgary, Calgary, Alberta</wicri:regionArea></affiliation></author><author><name sortKey="Robson, Paula J" sort="Robson, Paula J" uniqKey="Robson P" first="Paula J" last="Robson">Paula J. Robson</name><affiliation wicri:level="1"><nlm:affiliation>Alberta Health Services, Edmonton, Alberta, Canada; Department of Agricultural, Food and Nutritional Sciences, University of Alberta, Edmonton, Alberta, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Alberta Health Services, Edmonton, Alberta, Canada; Department of Agricultural, Food and Nutritional Sciences, University of Alberta, Edmonton, Alberta</wicri:regionArea></affiliation></author></analytic><series><title level="j">PloS one</title><idno type="eISSN">1932-6203</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Cohort Studies</term><term>Diet</term><term>Female</term><term>Folate Receptor 1 (blood)</term><term>Healthy Volunteers</term><term>Humans</term><term>Life Style</term><term>Male</term><term>Middle Aged</term><term>Pregnancy</term><term>Reference Values</term><term>Reproduction</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Folate Receptor 1</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Cohort Studies</term><term>Diet</term><term>Female</term><term>Healthy Volunteers</term><term>Humans</term><term>Life Style</term><term>Male</term><term>Middle Aged</term><term>Pregnancy</term><term>Reference Values</term><term>Reproduction</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Serum concentrations of the tumor-associated folate receptor 1 (FOLR1) protein may be a marker for early cancer detection, yet concentrations have also been detected in cancer-free women. We investigated the conditions associated with circulating FOLR1 protein in healthy individuals and sought to clarify the range of normal serum values.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24810481</PMID><DateCreated><Year>2014</Year><Month>05</Month><Day>09</Day></DateCreated><DateCompleted><Year>2015</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>5</Issue><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Conditions associated with circulating tumor-associated folate receptor 1 protein in healthy men and women.</ArticleTitle><Pagination><MedlinePgn>e96542</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0096542</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Serum concentrations of the tumor-associated folate receptor 1 (FOLR1) protein may be a marker for early cancer detection, yet concentrations have also been detected in cancer-free women. We investigated the conditions associated with circulating FOLR1 protein in healthy individuals and sought to clarify the range of normal serum values.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Sera of cancer-free men and women (N = 60) enrolled in a population-based cohort study in Alberta, Canada were analyzed for FOLR1 protein using an electrochemical luminescence immunoassay. Dietary, lifestyle, medical and reproductive history information was collected by questionnaires. Differences in serum FOLR1 concentrations between groups were assessed by non-parametric tests, and predictors of serum FOLR1 concentrations were estimated using multivariable linear regression.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Median serum FOLR1 concentration was higher in women (491 pg/ml, range = 327-693 pg/ml) than in men (404 pg/ml, range = 340-682 pg/ml), P = 0.001. FOLR1 concentration was also positively associated with vitamin A intake (P = 0.02), and showed positive trends with age and with oral contraceptive hormone use among women and an inverse trend with body mass index. All variables examined explained almost half of the variation in serum FOLR1 (model R2 = 0.44, P = 0.04); however, the retention of gender (P = 0.003) and vitamin A intake (P = 0.03) together explained 20% (P = 0.001) of serum FOLR1 variation. No other predictor was significant at P<0.05.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The positive association between serum FOLR1 concentration and female gender independent of an age effect suggests caution against statements to exploit serum FOLR1 for early cancer detection without further understanding the biological underpinnings of these observations. Serum FOLR1 concentrations may be influenced by the steroid retinoic acid (vitamin A) but do not appear to be associated with folate nutritional status. These findings require confirmation in larger independent studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kelemen</LastName><ForeName>Linda E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Department of Population Health Research, Alberta Health Services, Calgary, Alberta, Canada; Department of Medical Genetics, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brenton</LastName><ForeName>James D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom; Department of Oncology, University of Cambridge, Hutchison/Medical Research Council Research Centre, Cambridge, United Kingdom; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, United Kingdom; Cambridge Experimental Cancer Medicine Centre, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parkinson</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>C Whitaker</LastName><ForeName>Hayley</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom; Department of Oncology, University of Cambridge, Hutchison/Medical Research Council Research Centre, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piskorz</LastName><ForeName>Anna M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Csizmadi</LastName><ForeName>Ilona</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Population Health Research, Alberta Health Services, Calgary, Alberta, Canada; Departments of Oncology and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robson</LastName><ForeName>Paula J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Alberta Health Services, Edmonton, Alberta, Canada; Department of Agricultural, Food and Nutritional Sciences, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>05</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C548696">FOLR1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058975">Folate Receptor 1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2003 Jun 1;63(11):2820-8</RefSource><PMID Version="1">12782587</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2008 Oct 15;123(8):1968-73</RefSource><PMID Version="1">18661519</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 1999 Apr 16;230(2):215-24</RefSource><PMID Version="1">10216260</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Pharm. 2010 Dec 15;402(1-2):57-63</RefSource><PMID Version="1">20883757</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2168-72</RefSource><PMID Version="1">16172227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Detect Prev. 1985;8(1-2):71-5</RefSource><PMID Version="1">4064054</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2011 Oct;17(10):1315-9</RefSource><PMID Version="1">21926976</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2009;4(7):e6292</RefSource><PMID Version="1">19617914</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chronic Dis Can. 2006;27(2):51-9</RefSource><PMID Version="1">16867239</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 1976 Dec;48(6):911-21</RefSource><PMID Version="1">11860</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 1992 Sep;90(3):840-7</RefSource><PMID Version="1">1387884</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nutr Rev. 1982 Aug;40(8):234-5</RefSource><PMID Version="1">6752768</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2010 Dec;31(6):589-95</RefSource><PMID Version="1">20632143</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2005 May 15;65(10):4431-41</RefSource><PMID Version="1">15899836</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 2013 Nov;131(2):493-8</RefSource><PMID Version="1">23863359</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2013 Dec 10;31(35):4400-6</RefSource><PMID Version="1">24127448</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2004 Aug 15;160(4):339-49</RefSource><PMID Version="1">15286019</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2000 Feb;21(2):189-93</RefSource><PMID Version="1">10657957</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1997 Feb 11;36(6):1467-78</RefSource><PMID Version="1">9063895</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Public Health Nutr. 2007 Jan;10(1):88-96</RefSource><PMID Version="1">17212847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Ovarian Res. 2013 Apr 17;6(1):29</RefSource><PMID Version="1">23590973</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 1988 May;81(5):1398-406</RefSource><PMID Version="1">3366900</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1995 Aug 8;34(31):9951-61</RefSource><PMID Version="1">7632694</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Soc Nephrol. 1992 Oct;3(4):895-906</RefSource><PMID Version="1">1450366</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6006-9</RefSource><PMID Version="1">1631087</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Biochem. 2013 Oct;46(15):1462-8</RefSource><PMID Version="1">23528302</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Nutr. 1990;10:319-35</RefSource><PMID Version="1">2166548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Drug Deliv Rev. 2004 Apr 29;56(8):1127-41</RefSource><PMID Version="1">15094211</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1987 Sep;84(18):6546-9</RefSource><PMID Version="1">3476960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 1973 Aug;42(2):281-90</RefSource><PMID Version="1">4134494</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Lab Clin Med. 1974 Feb;83(2):207-14</RefSource><PMID Version="1">4855756</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2006 Jul 15;119(2):243-50</RefSource><PMID Version="1">16453285</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Chem. 2010 Oct 14;53(19):6811-24</RefSource><PMID Version="1">20666486</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1991 Oct 1;51(19):5329-38</RefSource><PMID Version="1">1717147</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Vitam Nutr Res. 1974;44(1):81-94</RefSource><PMID Version="1">4134130</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Diet Assoc. 2001 Mar;101(3):294-301</RefSource><PMID Version="1">11269606</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004032" MajorTopicYN="N">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058975" MajorTopicYN="N">Folate Receptor 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064368" MajorTopicYN="Y">Healthy Volunteers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008019" MajorTopicYN="N">Life Style</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012098" MajorTopicYN="N">Reproduction</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC4014514</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>01</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>04</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24810481</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0096542</ArticleId><ArticleId IdType="pii">PONE-D-14-03201</ArticleId><ArticleId IdType="pmc">PMC4014514</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000751 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000751 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:24810481
|texte= Conditions associated with circulating tumor-associated folate receptor 1 protein in healthy men and women.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:24810481" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |